Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating purpura

A drug, purpura technology, applied in the field of drugs, can solve the problem of easy recurrence of patients, and achieve the effect of reducing symptoms and controlling the onset of the disease

Inactive Publication Date: 2017-07-25
上海川沙天狮门诊部
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the treatment of purpura is mainly controlled by hormones and anticoagulant drugs, and patients are prone to relapse once they stop taking drugs or are exposed to triggers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] In order to make the content of the present invention more clearly understood, the present invention will be further described in detail below based on specific embodiments.

[0012] The medicine for treating purpura of the present invention comprises the following components: Radix Astragali 25g, Atractylodes macrocephala 15g, Chinese yam 15g, Divine Comedy 20g, Huanglian 10g, Gardenia 12g, Shuanghua 20g, Forsythia 15g, Cortex Phellodendri 10g, Baiji 10g, Radix Paeoniae Rubra 15g, Rubia 15g, Arborvitae leaves 15g, Panax notoginseng 2g, Agrimony 20g, Burnet charcoal 15g, Catechu 10g, Ligusticum chuanxiong 10g, Gallinus gallissima 20g, Yuanhu 15g, Cordyceps 0.5g.

[0013] Typical cases are as follows:

[0014] 1. Wang XX, male, 15 years old, had repeated skin purpura for 1 year. After taking the medicine for treating purpura of the present invention for three months (three months is a course of treatment), no skin purpura was seen, and the urine routine was normal, which...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating purpura. The medicine is prepared from the following raw materials by weight: 25g of radix astragali, 15g of white atractylodes rhizome, 15g of rhizoma dioscoreae, 20g of medicated leaven, 10g of rhizoma coptidis, 12g of fructus gardeniae, 20g of honeysuckle flowers, 15g of fructus forsythiae, 10g of cortex phellodendri, 10g of rhizoma bletillae, 15g of radix paeoniae rubra, 15g of radix rubiae, 15g of cacumen biotae, 2g of radix notoginseng, 20g of herba agrimoniae, 15g of carbonized sanguisorba root, 10g of catechu, 10g of rhizoma chuanxiong, 20g of endothelium corneum gigeriae galli, 15g of rhizoma corydalis, and 0.5g of cordyceps sinensis. For the medicine provided by the invention, the human in-vivo mechanisms including the globin of a patient are regulated, and thus the purpose of eliminating various immune complexes, metabolic toxins and pathogenic factors in the body of the patient for realizing effective treatment and control over the diseases is achieved.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating purpura. Background technique [0002] Purpura, also known as purpura, is one of the common hemorrhagic diseases in children. Purpura patients are often accompanied by epistaxis and dental bleeding, and even hematemesis, blood in the stool, and hematuria. This disease belongs to the category of blood syndrome, and the diseases such as "grape plague", "muscle epistaxis" and "spot poison" recorded in ancient books of traditional Chinese medicine have similarities with this disease. Primary disease comprises allergic purpura and thrombocytopenic purpura of western medicine. The age of onset of allergic purpura is mostly 3-14 years old, especially in school-age children. There are more men than women, and the onset is more frequent in spring. The age of onset of thrombocytopenic purpura is mostly 2-5 years old, and there is no difference in the incidence of men and women. The ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P37/08A61P9/14A61P7/04A61K35/57
CPCA61K35/57A61K36/00A61K36/068A61K36/14A61K36/236A61K36/258A61K36/284A61K36/355A61K36/48A61K36/481A61K36/634A61K36/65A61K36/66A61K36/71A61K36/718A61K36/73A61K36/739A61K36/74A61K36/744A61K36/756A61K36/8945A61K36/898A61K2300/00
Inventor 林志平
Owner 上海川沙天狮门诊部
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com